Animal/Veterinary Vaccines Market by Products, Diseases & Technology - Global Forecast to 2018

News provided by

Research and Markets

Apr 23, 2014, 03:59 ET

DUBLIN, April 23, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/npg4ct/animalveterinary) has announced the addition of the "Animal/Veterinary Vaccines Market by Products, Diseases & Technology - Global Forecast to 2018" report to their offering. 

Research and Markets Logo. (PRNewsFoto/PR NEWSWIRE EUROPE)
Research and Markets Logo. (PRNewsFoto/PR NEWSWIRE EUROPE)

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The animal vaccines market studied is segmented by products, animal diseases, and technologies that are involved in developing vaccines for veterinary administration. The global market, by products, is further segmented into seven segments, namely, companion animal vaccines, livestock, poultry, porcine, equine, aquaculture, and other veterinary vaccines. In 2012, livestock vaccines and porcine vaccines were two of the largest segments, accounting for 63% of the market share globally. The livestock vaccines market is further segmented into bovine vaccines and small ruminant vaccines, whereas the companion animal vaccines market is further segmented into canine vaccines and feline vaccines.

By technology, the market has segments like live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. DNA vaccines demonstrate tremendous growth opportunities due to factors such as added thermo-stability, cost effectiveness and easy production, and rapid development against emerging diseases.

The global market will be valued at $5.8 billion in 2013 and is expected to reach $8.6 billion by 2018, growing at a healthy CAGR of 8.1% from 2013 to 2018. Increasing investment opportunities in emerging and immature markets, growing prevalence of animal diseases, and increasing incidences of zoonotic diseases in humans are the key factors driving the growth of the market globally. Subsequently, rising maintenance costs incurred for storage of vaccines, major economies turning to vegetarian diets due to increasing obesity and other chronic disorders, as well as the persistent economic slowdown in major markets will prove to be restraining factors for this market.

The major players in this market are Pfizer (Zoetis) (U.S.), Merck (U.S.), Sanofi-Aventis (France), Bayer HealthCare (Germany), Virbac (France), Novartis (Switzerland), Boehringer Ingelheim (Germany), Heska Corporation (U.S.), Bioniche Animal Health Canada, Inc. (Canada), and Ceva (France). 

Key Topics Covered: 

1 Introduction
2 Executive Summary 
3 Market Overview 
4 Global Animal Vaccines Market, By Product
5 Global Animal Vaccines Market, By Disease
6 Animal Vaccines Market, By Technology 
7 Geographic Analysis
8 Competitive Landscape
9 Company Profiles

Companies Mentioned: 

  • Bayer Healthcare
  • Biogenesis Bago SA
  • Bioniche Animal Health Canada, Inc
  • Boehringer Ingelheim
  • Ceva (Ceva Sante Animale)
  • Heska Corporation
  • Indian Immunologicals Ltd
  • Lohmann Animal Health International
  • Merck
  • Merial (Animal Health Division Of Sanofi)
  • Novartis Animal Health, Inc
  • Protein Sciences Corporation
  • Virbac
  • Zoetis

For more information visit http://www.researchandmarkets.com/research/npg4ct/animalveterinary

Media Contact: Laura Wood, +353-1-481-1716, [email protected]

SOURCE Research and Markets